2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Advanced Liver Cancer Market?
The advanced liver cancer market is predicted to gain momentum due to an increase in enduring hepatitis infections. The protracted viral infections referred to can last beyond six months, and they have the potential to cause serious liver damage, cirrhosis, or even liver cancer. The escalation in enduring hepatitis infections can be ascribed to elements like insufficient screening, vaccination and tardy treatment access. Hepatitis B (HBV) or hepatitis C (HCV) chronic infections are notable contributors to liver cirrhosis and hepatocellular carcinoma (HCC), the most prevalent type of liver cancer. Persistent viral infections can lead to liver inflammation, liver damage, and eventually, over time, cancer. With these infections continuing to be relevant, an increased number of individuals are susceptible to advanced liver cancer. For example, the World Health Organization, located in Switzerland, reported that in 2022, chronic hepatitis B had affected 254 million people globally, and 1.2 million new cases were reported every year. Consequently, the surging prevalence of enduring hepatitis infections is fuelling the growth of the advanced liver cancer market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20706&type=smp
What is the Predicted Annual Growth Rate of theAdvanced Liver Cancer Market Impact Industry Trends by 2034?
Over the past few years, the advanced liver cancer market has seen significant growth. It’s predicted to expand from $1.89 billion in 2024 to $2.17 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 15.2%. Several factors have contributed to this growth during the historical period, including heightened awareness of liver cancer, a larger patient population, increased demand for targeted therapies, developed healthcare infrastructure, and a rise in demand for minimally invasive treatments.
In the upcoming years, the market size for advanced liver cancer is anticipated to experience robust growth. By 2029, the market value is projected to reach $3.78 billion, with a compound annual growth rate (CAGR) of 14.8%. This growth throughout the predicted period can be credited to the rising occurrence of liver cancer, expanded healthcare spending, growing prevalence of genetic diseases, the rising popularity of precision medicine, and an increase in the utilization of screening and diagnostic tests. Key trends identified within this forecast period include the incorporation of artificial intelligence in healthcare, the emergence of novel drugs and treatments, expansion in research and development undertakings, advancements in targeted therapeutics, and the surging demand for personalized medicine.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20706
What Are the Key Market Innovations in theAdvanced Liver Cancer Market Over the Coming Years?
Leading corporations in the advanced liver cancer market are concentrating on the development of groundbreaking medicines, such as human monoclonal antibodies, to enhance treatment effectiveness and reduce adverse reactions for improved patient results. Human monoclonal antibodies are lab-generated molecules that replicate the immune system’s role in attacking harmful pathogens or cancer cells. These antibodies specifically target antigens on these harmful elements, stimulating an immune reaction. For example, in October 2022, AstraZeneca, an American pharmaceutical firm, revealed that the US Food and Drug Administration (FDA) granted approval for Imjudo (tremelimumab) used in conjunction with Imfinzi (durvalumab) for treating adults with inoperable hepatocellular carcinoma (HCC), the most prevalent liver cancer form. This approval was given based on the findings from the HIMALAYA Phase III trial, which showed that this combination treatment cut the death risk by 22% compared to sorafenib, with around 31% of patients surviving after three years compared to 20% receiving sorafenib. Known as the STRIDE regimen, it consists of a single Imjudo dose followed by regular Imfinzi doses every four weeks, providing a fresh treatment alternative for patients with finite treatment options.
Who Are the Top Companies Driving Innovation and Growth in theAdvanced Liver Cancer Market?
Major companies operating in the advanced liver cancer market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck Co. Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Novartis AG, Eli Lilly and Company, Stryker Corporation, Agilent Technologies Inc., Eisai Co. Ltd., Jiangsu Hengrui Pharmaceutical Co. Ltd, Exelixis Inc., Sirtex Medical Limited, Eureka Therapeutics, Abbisko Therapeutics Co. Ltd., Binhui Biopharmaceutical Co. Ltd., Tempest Therapeutics Inc., Auransa Inc., Mina Alpha Limited, Jennerex Inc.
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/advanced-liver-cancer–global-market-report
Which Key Market Segments Comprise the Advanced Liver Cancer Market and Drive Its Revenue Growth?
The advanced liver cancer market covered in this report is segmented –
1) By Test Type: Imaging Test, Biopsy, Genomic Test, Other Test Types
2) By Technology: Fluorescent In Situ Hybridization, Next Generation Sequencing, Fluoroimmunoassay, Comparative Genomic Hybridization, Immunohistochemical, Other Technologies
3) By Distribution Channel: Direct Tenders, Retail Sales, Other Distribution Channel
4) By Application: Screening, Diagnostic And Predictive, Prognostic, Research
5) By End-User: Hospitals, Cancer Research Centers, Academic Institutes, Diagnostic Centers, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Imaging Test: Ultrasound, CT (Computed Tomography) Scan, MRI (Magnetic Resonance Imaging), PET (Positron Emission Tomography) Scan
2) By Biopsy: Needle Biopsy, Laparoscopic Biopsy, Surgical Biopsy
3) By Genomic Test: Next-Generation Sequencing (NGS), PCR (Polymerase Chain Reaction) Testing, Genetic Mutation Profiling
4) By Other Test Types: Serum Biomarker Testing, Liver Function Tests, Alpha-Fetoprotein (AFP) Test, Elastography Tests
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=20706&type=smp
Which Regions Are Emerging as Leaders in the Advanced Liver Cancer Market?
North America was the largest region in the advanced liver cancer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the advanced liver cancer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Global Advanced Liver Cancer Market 2025, By The Business Research Company:
Liver Cancer Diagnostics Global Market Report 2025
https://thebusinessresearchcompany.com/report/liver-cancer-diagnostics-global-market-report
Liver Diseases Therapeutics Global Market Report 2025
https://thebusinessresearchcompany.com/report/liver-diseases-therapeutics-global-market-report
Buccal Drug Delivery System Global Global Market Report 2025
https://thebusinessresearchcompany.com/report/buccal-drug-delivery-system-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: